Literature DB >> 16972816

The trials of separating bath water from baby: a review and critique of the MMPI-2 Restructured Clinical Scales.

David S Nichols1.   

Abstract

I review the development of the new set of MMPI-2 scales, the Restructured Clinical (RC) Scales (Tellegen et al., 2003). I identify several conceptual and methodological flaws in the construction of these scales, and I discuss the influence of a central shortcoming, the use of an atypical and depressively biased marker for unwanted ("first-factor") variance and its consequences for the RC Scales. I criticize the monograph introducing and describing the development of these scales for multiple important omissions. I provide examples of RC Scales in which relevant variances were overextracted or underextracted in the process of their construction. I introduce and apply the concept of "construct drift" to the RC Scales corresponding to the MMPI-2 (Butcher, Dahlstrom, Graham, Tellegen, & Kaemmer, 1989) Clinical Scales, Psychasthenia and Hypomania. I conclude that the RC Scales are highly redundant with and function as routinely scored Content scales and that their designation as Clinical Scales is at best tenuous. I present two more appropriate, unbiased markers for the first factor along with the description of several nonintrusive strategies for increasing the independence of the Clinical Scales without compromising their syndromal fidelity.

Entities:  

Mesh:

Year:  2006        PMID: 16972816     DOI: 10.1207/s15327752jpa8702_02

Source DB:  PubMed          Journal:  J Pers Assess        ISSN: 0022-3891


  2 in total

1.  Advances in applications of item response theory to clinical assessment.

Authors:  Michael L Thomas
Journal:  Psychol Assess       Date:  2019-03-14

2.  The MMPI-2 restructured clinical scales in the assessment of posttraumatic stress disorder and comorbid disorders.

Authors:  Erika J Wolf; Mark W Miller; Robert J Orazem; Mariann R Weierich; Diane T Castillo; Jaime Milford; Danny G Kaloupek; Terence M Keane
Journal:  Psychol Assess       Date:  2008-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.